Pfizer Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Buy" and an average price target of $29.19. The average 1-year stock price forecast is 12.62% higher than the current stock price, while the lowest is $24 (-7.41%) and the highest is $36 (+38.89%).

Price Target: $29.19 (+12.62%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$24	$29.19	$28	$36
Change	-7.41%	+12.62%	+8.02%	+38.89%

Analyst Ratings

The average analyst rating for Pfizer stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	8	9	9	9
Buy	3	2	2	2	2	2
Hold	15	16	15	15	15	16
Sell	0	2	2	2	2	1
Strong Sell	1	1	1	1	1	1
Total	26	28	28	29	29	29

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mohit Bansal Wells Fargo	Wells Fargo	Hold Reiterates $28	Hold	Reiterates	$28	+8.02%	Jun 11, 2026
Courtney Breen Bernstein	Bernstein	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 10, 2026
Trung Huynh RBC Capital	RBC Capital	Hold Upgrades $25	Hold	Upgrades	$25	-3.55%	Jun 9, 2026
Asad Haider Goldman Sachs	Goldman Sachs	Hold Maintains $26	Hold	Maintains	$26	+0.31%	Jun 9, 2026
Geoff Meacham Citi	Citi	Hold Maintains $27	Hold	Maintains	$27	+4.17%	Jun 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

61.69B

from 62.58B

-1.42%

from 62.58B

Revenue Next Year

59.32B

from 61.69B

-3.84%

from 61.69B

EPS This Year

2.96

from 3.22

-8.11%

from 3.22

EPS Next Year

2.83

from 2.96

-4.38%

from 2.96

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	81.29B	101.18B	59.55B	63.63B	62.58B	61.69B
Revenue Growth	95.17%	24.47%	-41.14%	6.84%	-1.65%	-1.42%
Gross Profit	50.60B	67.08B	35.57B	46.44B	47.44B	46.24B
Gross Margin	62.25%	66.30%	59.72%	72.98%	75.81%	74.96%
Operating Income	26.98B	39.84B	6.32B	15.56B	19.16B	21.78B
Net Income	21.98B	31.37B	2.12B	8.03B	7.77B	11.07B
EPS	-	-	-	-	3.22	2.96
EPS Growth	-	-	-	-	3.54%	-8.11%
Forward PE	10.64	10.82	19.25	9.91	8.54	8.76
Dividend / Share	1.56	1.60	1.64	1.68	1.72	1.75
Dividend Growth	-	2.56%	2.50%	2.44%	2.38%	1.87%
Free Cash Flow	30.94B	25.49B	1.67B	12.28B	13.43B	19.52B
No. Analysts	-	-	-	-	-	26

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	63.1B
Avg	61.7B
Low	59.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	0.9%
Avg	-1.4%
Low	-4.9%

EPS Forecast

EPS	2026	2027	2028
High	3.12
Avg	2.96
Low	2.80

EPS Growth

EPS Growth	2026	2027	2028
High	-3.1%
Avg	-8.1%
Low	-13.0%